Soliris User Reviews & Ratings
Soliris has an average rating of 7.3 out of 10 from a total of 4 reviews on Drugs.com. 33% of reviewers reported a positive experience, while 0% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Myasthenia Gravis | 2 reviews for Myasthenia Gravis | 14 medications | |
Paroxysmal Nocturnal Hemoglobinuria | 2 reviews for Paroxysmal Nocturnal Hemoglobinuria | 8 medications |
- rwm...
- Taken for 1 to 6 months
- December 31, 2024
For Paroxysmal Nocturnal Hemoglobinuria "Immediate improvement after 2 infusions, with an increase in hemoglobin / hematocrit. After vaccines for HepA and HepB 2 weeks prior to receiving treatment, I was given 4 weekly infusions, then 4 bi-weekly infusions which brought all my numbers into normal range. I was moved to treatments every 8 weeks, which continue. First 4 infusions were 600 mg. Infusions following have been 900 mg. I have experienced face flushing and increased energy with some agitation for 1 to 2 days following each infusion. I am retired and treatments are covered by Medicare and my supplemental Blue Cross / Blue Shield policy."
- Anonymous
- Taken for 2 to 5 years
- May 23, 2024
For Myasthenia Gravis "I have been taking Soliris for about 5 years. It has been great. I have only had to have pheresis and IVIGs a couple of times since I started it. I have the side effects though. I have a new symptom, which is burning feet. I don't know if it's from the drug or not?"
Frequently asked questions
- How does Ultomiris compare to Soliris for PNH?
- How does Soliris work for PNH?
- How does Empaveli compare to Soliris?
- What biosimilars have been approved in the United States?
- Nic...
- Taken for 1 to 6 months
- July 10, 2019
For Myasthenia Gravis "I started taking Soliris in January 2019, and by July 2019, I had throat cancer, which was undetectable by CT scan but was confirmed by tissue biopsy."
More about Soliris (eculizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
For Paroxysmal Nocturnal Hemoglobinuria "This drug is for Paroxysmal Nocturnal Hemoglobinuria (PNH) but disease is heterogeneous. I feel worse being on it. Doctors push it-patients just do it. It is too much work. I never should have started."